首页> 外国专利> CLONOGENIC NATURAL KILLER (NK) CELL POPULATIONS AND METHODS OF PRODUCING AND USING SUCH POPULATIONS

CLONOGENIC NATURAL KILLER (NK) CELL POPULATIONS AND METHODS OF PRODUCING AND USING SUCH POPULATIONS

机译:克隆性自然杀手(NK)细胞种群以及生产和使用这类种群的方法

摘要

The present invention relates to novel methods for in vitro expansion of clonogenic natural killer (NK) cells. The methods utilize the stimulatory effects of trans-presented IL-15 in cell culture using feeder cells to expand isolated NK cell clones with a predetermined phenotypic trait of interest. The resultant clonogenic NK cell populations are homogenous, in contrast to heterogenous, crude NK cells typically isolated and expanded from a human tissue sample. The present invention also relates to feeder cells that are genetically engineered to trans-present IL-15 involving co-expressing human IL-15 and IL-15 receptor α subunit (IL-15Rα) that are capable of stimulating the expansion of NK cell clones in vitro. The present invention further relates to viable, functional clonogenic NK cell populations with the predetermined phenotypic trait of interest obtained via the above in vitro expansion methods and their use in personalized medicine to treat diseases, including leukemia, lymphoma and human hematopoietic cell transplantation (HCT), in drug screening and in basic and translational studies involving NK cells.
机译:本发明涉及用于克隆人自然形成的自然杀伤(NK)细胞的体外扩增的新方法。该方法利用饲养细胞在细胞培养中利用转表达的IL-15的刺激作用来扩增具有预定目标表型特征的分离的NK细胞克隆。与通常从人组织样品中分离并扩增的异质粗NK细胞相反,所得的克隆性NK细胞群体是同质的。本发明还涉及经遗传工程改造以转染IL-15的饲养细胞,所述IL-15涉及共表达人IL-15和IL-15受体α亚基(IL-15Rα),其能够刺激NK细胞克隆的扩增。 体外。本发明进一步涉及通过上述体外扩增方法获得的具有预定目标表型特征的可行的功能性克隆性NK细胞群体及其在个性化药物中的用途,所述疾病包括白血病,淋巴瘤和人造血细胞移植(HCT),药物筛选以及涉及NK细胞的基础和翻译研究。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号